Kevin R Krull1, Satoshi Minoshima2, Michelle Edelmann3, Brannon Morris4, Noah D Sabin5, Tara M Brinkman3, Gregory T Armstrong3, Leslie L Robison3, Melissa M Hudson6, Barry Shulkin5. 1. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee kevin.krull@stjude.org. 2. Department of Radiology, University of Washington, Seattle, Washington. 3. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 4. Athens Neurological Associates, Athens, Georgia. 5. Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and. 6. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Abstract
UNLABELLED: The objective of this study was to examine associations between regional brain metabolism, as measured by (18)F-FDG PET, and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation. METHOD: Thirty-eight adult survivors of ALL were randomly selected from a large cohort treated with cranial radiation therapy (19 with 18 Gy and 19 with 24 Gy of exposure). At a mean age of 26.4 (range, 22.3-37.4) years, and 23.5 (range, 20.4-32.8) years since diagnosis, patients underwent comprehensive neurocognitive evaluations and brain (18)F-FDG PET imaging during a resting condition. (18)F-FDG PET images were analyzed stereotactically, and pixel values were normalized to global activity. Predefined region-of-interest and voxel-based correlation analyses were performed. RESULTS: Compared with national norms, survivors demonstrated lower vocabulary (P < 0.001), reading (P < 0.001), mathematics (P < 0.001), working memory (P < 0.001), oral naming speed (P < 0.001), and cognitive flexibility (P < 0.001). Metabolic activity was higher in basal gangliar structures for those treated with 24 Gy of cranial radiation therapy (P = 0.04). Metabolic activity was positively correlated with oral naming speed in both lateral frontal lobes (ρ = 0.48 and 0.47 for right and left frontal regions, respectively, P < 0.01) and negatively correlated with cognitive flexibility in the sections of the basal ganglia (P < 0.01 for both caudate and putamen). CONCLUSION: Neurocognitive impairment in long-term survivors of ALL treated with cranial radiation appears to be associated with increased metabolic activity in frontal cerebral cortical and subcortical regions in the basal ganglia, suggesting decreased efficiency of the frontostriatal brain circuit.
UNLABELLED: The objective of this study was to examine associations between regional brain metabolism, as measured by (18)F-FDG PET, and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation. METHOD: Thirty-eight adult survivors of ALL were randomly selected from a large cohort treated with cranial radiation therapy (19 with 18 Gy and 19 with 24 Gy of exposure). At a mean age of 26.4 (range, 22.3-37.4) years, and 23.5 (range, 20.4-32.8) years since diagnosis, patients underwent comprehensive neurocognitive evaluations and brain (18)F-FDG PET imaging during a resting condition. (18)F-FDG PET images were analyzed stereotactically, and pixel values were normalized to global activity. Predefined region-of-interest and voxel-based correlation analyses were performed. RESULTS: Compared with national norms, survivors demonstrated lower vocabulary (P < 0.001), reading (P < 0.001), mathematics (P < 0.001), working memory (P < 0.001), oral naming speed (P < 0.001), and cognitive flexibility (P < 0.001). Metabolic activity was higher in basal gangliar structures for those treated with 24 Gy of cranial radiation therapy (P = 0.04). Metabolic activity was positively correlated with oral naming speed in both lateral frontal lobes (ρ = 0.48 and 0.47 for right and left frontal regions, respectively, P < 0.01) and negatively correlated with cognitive flexibility in the sections of the basal ganglia (P < 0.01 for both caudate and putamen). CONCLUSION:Neurocognitive impairment in long-term survivors of ALL treated with cranial radiation appears to be associated with increased metabolic activity in frontal cerebral cortical and subcortical regions in the basal ganglia, suggesting decreased efficiency of the frontostriatal brain circuit.
Authors: Kevin R Krull; Nan Zhang; Aimee Santucci; Deo Kumar Srivastava; Matthew J Krasin; Larry E Kun; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Gregory T Armstrong Journal: Blood Date: 2013-06-06 Impact factor: 22.113
Authors: Bernward Zeller; Christian K Tamnes; Adriani Kanellopoulos; Inge K Amlien; Stein Andersson; Paulina Due-Tønnessen; Anders M Fjell; Kristine B Walhovd; Lars T Westlye; Ellen Ruud Journal: J Clin Oncol Date: 2013-04-15 Impact factor: 44.544
Authors: M Kähkönen; L Metsähonkala; H Minn; T Utriainen; T Korhonen; M K Norvasuo-Heilä; A Harila-Saari; T Aärimaa; H Suhonen-Polvi; U Ruotsalainen; O Solin; T T Salmi Journal: Cancer Date: 2000-02-01 Impact factor: 6.860
Authors: Gregory T Armstrong; Wilburn E Reddick; Ronald C Petersen; Aimee Santucci; Nan Zhang; Deokumar Srivastava; Robert J Ogg; Claudia M Hillenbrand; Noah Sabin; Matthew J Krasin; Larry Kun; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull Journal: J Natl Cancer Inst Date: 2013-04-12 Impact factor: 13.506
Authors: Kevin R Krull; Tara M Brinkman; Chenghong Li; Gregory T Armstrong; Kirsten K Ness; Deo Kumar Srivastava; James G Gurney; Cara Kimberg; Matthew J Krasin; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson Journal: J Clin Oncol Date: 2013-11-04 Impact factor: 44.544
Authors: Paulo R Dellani; Stefan Eder; Joachim Gawehn; Goran Vucurevic; Andreas Fellgiebel; Matthias J Müller; Heinz Schmidberger; Peter Stoeter; Peter Gutjahr Journal: J Magn Reson Imaging Date: 2008-06 Impact factor: 4.813
Authors: Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison Journal: JAMA Date: 2013-06-12 Impact factor: 56.272
Authors: Timo B Woost; Juergen Dukart; Stefan Frisch; Henryk Barthel; Osama Sabri; Karsten Mueller; Matthias L Schroeter Journal: Neuroimage Clin Date: 2013-05-27 Impact factor: 4.881
Authors: Pinki K Prasad; Kristina K Hardy; Nan Zhang; Kim Edelstein; Deokumar Srivastava; Lonnie Zeltzer; Marilyn Stovall; Nita L Seibel; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Kevin Krull Journal: J Clin Oncol Date: 2015-07-06 Impact factor: 44.544
Authors: Kevin R Krull; Kristina K Hardy; Lisa S Kahalley; Ilse Schuitema; Shelli R Kesler Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Matthäus Majewski; Patrick Ostheim; Zoya Gluzman-Poltorak; Vladimir Vainstein; Lena Basile; Simone Schüle; Michael Haimerl; Christian Stroszczynski; Matthias Port; Michael Abend Journal: PLoS One Date: 2021-07-21 Impact factor: 3.240
Authors: Tien T Tang; Janice A Zawaski; Shelli R Kesler; Christine A Beamish; Wilburn E Reddick; John O Glass; Darrell H Carney; Omaima M Sabek; David R Grosshans; M Waleed Gaber Journal: Neurooncol Adv Date: 2019-07-02
Authors: Tien T Tang; Janice A Zawaski; Shelli Kesler; Christine A Beamish; Taeko Inoue; Emma C Perez; Lawrence Bronk; Falk Poenisch; Tina M Briere; Omaima M Sabek; David R Grosshans; M Waleed Gaber Journal: Int J Radiat Oncol Biol Phys Date: 2021-09-09 Impact factor: 7.038